SAR-260301

SynDRA canonical compound SYN0037816 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	PIK3C2G \| PIK3C3 \| PIK3CA \| PIK3CB \| PIK3CD
Mechanism of action	pi3k inhibitor
Indication	melanoma
Disease area	oncology

All known targets

PIK3CB
PIK3C2G
PIK3C3
PIK3CA
PIK3CD

Mechanisms of action (all sources)

PIK3CB INHIBITOR
PI3-kinase p110-beta subunit inhibitor
PI3K inhibitor

Cross-references

PubChem CID: 135565159
ChEMBL: CHEMBL3112866
PDB: J82

Synonyms

SAR260301
RefChem:181306
PI3K-beta Inhibitor SAR260301
MFCD27987912
compound 28 [PMID: 24387221]
4bfr
UAXHPOBBKRWJGA-ZDUSSCGKSA-N
J82
UNII-33639WNC7Q
GTPL8793
orb1307758
SCHEMBL1027765
GLXC-15264
KAC61213
AKOS025291099
AKOS040742610
AS-35206
DA-77684
HY-15837
CS-0009322

Look up SAR-260301 in the interactive SynDRA portal →